Immutep Ltd - ADR (IMMP) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB +0,25%	1 104,10	+2,73	+0,25%	—	1 101,37	1 103,63	1 105,31	1 091,41	—	—
SIXC Communications SIXC Communications	SIXC −1,50%	604,16	−9,19	−1,50%	—	613,35	613,35	613,35	601,49	—	—
SIXE Energy SIXE Energy	SIXE −0,09%	1 197,81	−1,02	−0,09%	—	1 198,83	1 199,68	1 199,75	1 182,41	—	—
SIXI Industrials SIXI Industrials	SIXI −0,88%	1 740,41	−15,54	−0,88%	—	1 755,95	1 754,06	1 756,03	1 734,69	—	—
SIXM Financials SIXM Financials	SIXM −0,64%	634,44	−4,07	−0,64%	—	638,51	637,41	637,41	633,05	—	—
SIXR Staples SIXR Staples	SIXR −0,31%	840,90	−2,62	−0,31%	—	843,52	843,35	846,40	837,93	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,38%	215,13	−0,82	−0,38%	—	215,95	215,95	216,84	215,06	—	—
SIXT Technology SIXT Technology	SIXT +2,86%	3 228,71	+89,80	+2,86%	—	3 138,91	3 189,30	3 230,85	3 174,76	—	—
SIXU Utilities SIXU Utilities	SIXU +0,16%	935,87	+1,50	+0,16%	—	934,37	934,72	938,26	927,50	—	—
SIXV Health care SIXV Health care	SIXV −1,37%	1 457,12	−20,31	−1,37%	—	1 477,43	1 474,12	1 474,12	1 451,80	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0,83%	2 399,84	+19,65	+0,83%	—	2 380,19	2 389,34	2 403,04	2 380,47	—	—

IMMP:NASDAQ

Immutep Ltd - ADR

0,57 USD

+0,37%

(+0,0021) 1 D

0,58 USD

+1,22% (+0,0070)

Etter stengetid

Stengt: 24. apr., 16:00:00 GMT-4 · USD

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for IMMP …

Åpne

0,56 USD

Høy

0,58 USD

Lav

0,56 USD

Markedsverdi

73,53 mill.

Snittvolum

28,73 mill.

Volum

1,89 mill.

52 u høy

3,53 USD

52 u lav

0,29 USD

EPS

−0,41 USD

Beta

2,20

Utestående aksjer

147,37 mill.

Antall ansatte

Relaterte aksjer

AGAE

Allied Gaming & Entertainment Inc

ioneer American Depositary Shares

Nyhetssaker

Fra kilder på nettet

PR Newswire

for 1 døgn siden

Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP

Meyka

for 2 døgn siden

IMM.AX Stock Surges 1.37% on ASCO Presentation News, 24 Apr 2026

Profil

Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally built on CVac, a therapeutic cancer vaccine. In late 2014 the privately held French immunotherapy company Immutep SA was purchased by Prima Biotech. Prima currently has three main products in its pipeline, all acquired with Immutep: Eftilagimod alpha, which is recombinant soluble LAG-3, used as an activator of antigen presenting cells. This product has completed a Phase IIa clinical study, where it doubled the expected response rate in HER2-negative metastatic breast cancer. IMP731, a depleting monoclonal antibody for autoimmune diseases, targeting LAG-3+ activated T cells. This antibody has been licensed to GlaxoSmithKline. IMP701, an antagonist monoclonal antibody to LAG3 for use in cancer. This product has been licensed to Novartis. Wikipedia

Om Immutep Ltd - ADR

Administrerende direktørMarc Voigt

Ansatte19

Grunnlagt2001

Hovedkontor-

Sektor-

Nettstedimmutep.com

Alle verdier i AUD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	948,05k	948,05k	3,01 mill.	3,01 mill.
Varekostnad	18,04 mill.	18,04 mill.	23,31 mill.	23,31 mill.
Direkte driftskostnader	18,04 mill.	18,04 mill.	23,31 mill.	23,31 mill.
Utgifter til forskning og utvikling	-	-	-	-
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	2,21 mill.	2,21 mill.	2,71 mill.	2,71 mill.
Driftskostnader	2,21 mill.	2,21 mill.	2,71 mill.	2,71 mill.
Totale driftskostnader	20,25 mill.	20,25 mill.	26,03 mill.	26,03 mill.
Driftsinntekter	−19,30 mill.	−19,30 mill.	−23,01 mill.	−23,01 mill.
Andre ikke-operasjonelle inntekter	195,00	195,00	−256,17k	−256,17k
EBT inkludert uvanlige elementer	−19,53 mill.	−19,53 mill.	−22,43 mill.	−22,43 mill.
EBT uten uvanlige elementer	−19,49 mill.	−19,49 mill.	−22,42 mill.	−22,42 mill.
Kostnad for inntektsskatt	-	-	-	-
Faktisk avgiftssats	-	-	-	-
Andre driftskostnader	-	-	-	-
Nettoinntekt	−19,53 mill.	−19,53 mill.	−22,43 mill.	−22,43 mill.
Netto fortjenestemargin	−2 059,84 %	−2 059,84 %	−744,36 %	−744,36 %
Resultat per aksje	-	-	-	-
Rente- og investeringsinntekter	1,08 mill.	1,08 mill.	798,85k	798,85k
Rentekostnader	−9,90k	−9,90k	−9,65k	−9,65k
Netto rentekostnader	1,07 mill.	1,07 mill.	789,20k	789,20k
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	−18,75 mill.	−18,75 mill.	−22,45 mill.	−22,45 mill.
Gevinst eller tap ved salg av eiendeler	593,00	593,00	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning